PFM Health Sciences’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
PFM Health Sciences's TNGX Position: Q3 2026 in Review
PFM Health Sciences sold out of Tango Therapeutics (TNGX) in Q3 2026, closing a stake of 326,047 shares — an estimated $10.2M sold.
PFM Health Sciences first reported a position in TNGX in Q1 2026 and held it in 2 quarters. The position peaked at $10.2M in Q2 2026. 211 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- PFM Health Sciences reported no remaining Tango Therapeutics position as of Q3 2026 after selling out during the quarter.
- PFM Health Sciences sold 326,047 Tango Therapeutics shares in Q3 2026, an estimated $10.2M.
- PFM Health Sciences first reported a position in Tango Therapeutics in Q1 2026 and held it in 2 quarters.
- PFM Health Sciences's Tango Therapeutics position peaked at $10.2M in Q2 2026.
- 211 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.